Kathleen Borthwick - 28 Jul 2023 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
SVP, Interim CFO
Signature
/s/ Edgar Cale, Attorney-in-Fact
Issuer symbol
PASG
Transactions as of
28 Jul 2023
Net transactions value
$0
Form type
4
Filing time
28 Jul 2023, 18:34:32 UTC
Next filing
03 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Employee Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 28 Jul 2023 Common Stock 20,000 $0.8773 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vested as to 25% of the total shares on July 28, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.